Read the FDA Reports about their Fosamax Investigation

Fosamax (Alendronate Sodium), distributed by Merck, was approved by the FDA in 1995. Since then, there have been many dangerous health risks associated with those taking the Fosamax drug, including many cases of Osteonecrosis of the Jaw, also known as Dead Jaw.

This and other dangerous side effects began to surface as early as 1996. Read the FDA Reports by following the links below:

Dear Doctor Letter

2001 Fosamax Label Change

2004 Fosamax Label Change

2004 Fosamax Postmarketing Review

2004 FDA Fosamax Event Review

Click To Talk To Us Online

2001 Fosamax Label Change

2001 Fosamax Label Change
FDA Report - 2001 Fosamax Label Change

Dear Doctor (1996)

Dear Doctor - 1996 Letter written to Merck about Fosamax
Dear Doctor - 1996 Letter written to Merck about Fosamax

Fosamax and Cancer Patients

Fosamax and Cancer Patients - Are you at risk?
Fosamax and Cancer - Find out if you should be concerned

Name

Phone

strictly confidential

Your Question

First Name
Last Name
Home Phone
Work Phone
Best Time to Call
City and State
Email
When did you start taking Fosamax?
When did you stop taking Fosamax?
How were you taking Fosamax?
What dosage were you taking?
Did you develop Osteonecrosis of the Jaw (Dead Jaw)?	Yes
How long were you taking Fosamax before you developed Osteonecrosis?
Did you have dental work done in the month before the Osteonecrosis developed?	Yes No
What type of treatment did you have?
Please describe any ongoing complications:
Additional Comments: